OA09631A - Interleukin-1 inhibitors - Google Patents

Interleukin-1 inhibitors

Info

Publication number
OA09631A
OA09631A OA59901A OA59901A OA09631A OA 09631 A OA09631 A OA 09631A OA 59901 A OA59901 A OA 59901A OA 59901 A OA59901 A OA 59901A OA 09631 A OA09631 A OA 09631A
Authority
OA
OAPI
Prior art keywords
interleukin
inhibitors
Prior art date
Application number
OA59901A
Other languages
English (en)
Inventor
Charles H Hannoum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of OA09631A publication Critical patent/OA09631A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA59901A 1988-05-27 1990-11-23 Interleukin-1 inhibitors OA09631A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03

Publications (1)

Publication Number Publication Date
OA09631A true OA09631A (en) 1993-04-30

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59901A OA09631A (en) 1988-05-27 1990-11-23 Interleukin-1 inhibitors

Country Status (9)

Country Link
JP (2) JP3192651B2 (no)
KR (1) KR970002917B1 (no)
BR (1) BR8907457A (no)
DK (1) DK172763B1 (no)
FI (2) FI109206B (no)
HU (3) HU215434B (no)
NO (2) NO316122B1 (no)
OA (1) OA09631A (no)
WO (1) WO1989011540A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
CA2081774A1 (en) * 1990-05-01 1991-11-02 John Stephen Haskill Interleukin-1 antagonist and uses thereof
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1442132A2 (en) * 2001-10-26 2004-08-04 Novartis AG Methods for the treatment of osteoarthritis and compositions thereof
AU2003243139B2 (en) 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
JP5718640B2 (ja) 2007-08-21 2015-05-13 アムジエン・インコーポレーテツド ヒトｃ−ｆｍｓ抗原結合性タンパク質
CN102209557A (zh) * 2008-09-12 2011-10-05 埃克斯生物科技公司 靶向病原性单核细胞
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
US20140308294A1 (en) 2011-04-15 2014-10-16 Merck Patent Gmbh Anti-IL-1R1 Inhibitors For Use in Cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
WO2017156058A1 (en) 2016-03-08 2017-09-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8820676A (nl) * 1987-08-26 1989-07-03 Biogen Inc Biologische materialen, werkwijzen ter bereiding van biologische materialen en de toepassing van dergelijke materialen in therapie.

Also Published As

Publication number Publication date
HU215434B (hu) 1999-04-28
WO1989011540A1 (en) 1989-11-30
NO20014783D0 (no) 2001-10-01
NO20014783L (no) 1991-01-28
FI905812A0 (fi) 1990-11-26
BR8907457A (pt) 1991-04-02
NO316917B1 (no) 2004-06-21
HU9803037D0 (en) 1999-11-29
AU633831B2 (en) 1993-02-11
AU3746989A (en) 1989-12-12
NO905090D0 (no) 1990-11-23
FI20020545A (fi) 2002-03-21
DK8591D0 (da) 1991-01-18
JPH03505279A (ja) 1991-11-21
KR970002917B1 (ko) 1997-03-12
FI109206B (fi) 2002-06-14
DK8591A (da) 1991-01-18
JP3192651B2 (ja) 2001-07-30
HU222810B1 (hu) 2003-11-28
NO316122B1 (no) 2003-12-15
NO905090L (no) 1991-01-28
HU893412D0 (en) 1991-05-28
JP2001029093A (ja) 2001-02-06
DK172763B1 (da) 1999-07-05

Similar Documents

Publication Publication Date Title
AU7683391A (en) Modified interleukin-1 inhibitors
OA09631A (en) Interleukin-1 inhibitors
GB8904516D0 (en) Screwdriver
YU208688A (en) Vice
GR862032B (en) Dopamine-b-hydroxylase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
ZW21586A1 (en) Dopamine-b-hydroxylase inhibitors
IL92643A0 (en) Renin inhibitors
ZW9087A1 (en) Dopamine-b-hydroxylase inhibitors
GB8808176D0 (en) Centre finding tapemeasure
ZA894052B (en) Interleukin-1 inhibitors
IE882591L (en) Interleukin-1 inhibitors
GB2223701B (en) Nut
GR860362B (en) Dopamine -b-hydroxylase inhibitors
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE880785L (en) Inhibitors of interleukin-1 release
BG46057A1 (en) Oureasive activity inhibitor
IE883871L (en) Dobamine-beta-hydroxylase inhibitors.
IE872276L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE862056L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE860327L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
IE881856L (en) Aromatase inhibitors
GB8829723D0 (en) Tipredane formulations